BIOXODES

bioxodes-logo

Founded by an experienced group of seasoned healthcare and biotech executives with extensive experience in research, drug development, and commercialisation, Bioxodes is developing a portfolio of high value products derived from natural sources based on research conducted by Prof. Edmond Godfroid. The research was conducted in collaboration with academic groups from Université Catholique de Louvain, Facultés Universitaires Notre Dame de la Paix Namur, and Université de Liège as well as with... the Université de Neuchâtel, Switzerland. The Company’s lead programme, Ir-CPI, is the first in a novel class of antithrombotics, and is being developed for the prevention of thrombosis in a range of applications including cardiopulmonary bypass grafting and percutaneous coronary intervention. Thanks to a novel mechanism of action, Ir-CPI is potentially the world’s first injectable antithrombotic which can be used in all patient groups without causing high levels of bleeding and potentially without needing to be reversed or washed out at the end of critical procedures.

#SimilarOrganizations #People #Financial #Website #More

BIOXODES

Industry:
Biotechnology Health Care Therapeutics

Founded:
2013-01-01

Address:
Marche-en-famenne, Luxembourg, Belgium

Country:
Belgium

Website Url:
http://www.bioxodes.com

Total Employee:
11+

Status:
Active

Total Funding:
2.6 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apache Mobile Non Scaleable Content Microsoft Exchange Online Organization Schema Office 365 Mail


Similar Organizations

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Current Employees Featured

not_available_image

Oliver Boucher
Oliver Boucher Executive Director @ Bioxodes
Executive Director

edmond-godfroid_image

Edmond Godfroid
Edmond Godfroid Founder, Chief Executive Officer & Chief Scientific Officer @ Bioxodes
Founder, Chief Executive Officer & Chief Scientific Officer

Founder


edmond-godfroid_image

Edmond Godfroid

Investors List

european-commission_image

European Commission

European Commission investment in Seed Round - Bioxodes

Official Site Inspections

http://www.bioxodes.com

  • Host name: 172-105-77-93.ip.linodeusercontent.com
  • IP address: 172.105.77.93
  • Location: Frankfurt am Main Germany
  • Latitude: 50.1188
  • Longitude: 8.6843
  • Timezone: Europe/Berlin
  • Postal: 60313

Loading ...

More informations about "Bioxodes" on Search Engine